218 related articles for article (PubMed ID: 32314157)
1. Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy.
Farrow NE; Raman V; Williams TP; Nguyen KY; Tyler DS; Beasley GM
Ann Surg Oncol; 2020 Dec; 27(13):5121-5125. PubMed ID: 32314157
[TBL] [Abstract][Full Text] [Related]
2. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
3. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
Eroglu Z; Broman KK; Thompson JF; Nijhuis A; Hieken TJ; Kottschade L; Farma JM; Hotz M; Deneve J; Fleming M; Bartlett EK; Sharma A; Dossett L; Hughes T; Gyorki DE; Downs J; Karakousis G; Song Y; Lee A; Berman RS; van Akkooi A; Stahlie E; Han D; Vetto J; Beasley G; Farrow NE; Hui JYC; Moncrieff M; Nobes J; Baecher K; Perez M; Lowe M; Ollila DW; Collichio FA; Bagge RO; Mattsson J; Kroon HM; Chai H; Teras J; Sun J; Carr MJ; Tandon A; Babacan NA; Kim Y; Naqvi M; Zager J; Khushalani NI
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002183
[TBL] [Abstract][Full Text] [Related]
4. Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 years.
Baecher H; Gerken M; Knoedler L; Knoedler S; Alfertshofer M; Klinkhammer-Schalke M; Berneburg M; Drexler K; Haferkamp S
J Plast Reconstr Aesthet Surg; 2024 May; 92():33-47. PubMed ID: 38489985
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection.
Broman KK; Bettampadi D; Pérez-Morales J; Sun J; Kirichenko D; Carr MJ; Eroglu Z; Tarhini AA; Khushalani N; Schabath MB; Sarnaik A; Sondak VK; Zager JS
Ann Surg Oncol; 2021 Nov; 28(12):6978-6985. PubMed ID: 34363118
[TBL] [Abstract][Full Text] [Related]
7. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
[TBL] [Abstract][Full Text] [Related]
8. Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study.
Zhong J; Zou Z; Hu T; Sun W; Wang C; Yan W; Luo Z; Liu X; Xu Y; Chen Y
Clin Exp Med; 2023 Nov; 23(7):4003-4010. PubMed ID: 37300655
[TBL] [Abstract][Full Text] [Related]
9. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
Persa OD; Knuever J; Mauch C; Schlaak M
J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
[TBL] [Abstract][Full Text] [Related]
10. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Broman KK; Hughes TM; Bredbeck BC; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; O'shea K; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Hotz M; Farma JM; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley GM; Hui JYC; Been L; Kruijff S; Sinco B; Sarnaik AA; Sondak VK; Zager JS; Dossett LA;
Ann Surg; 2023 May; 277(5):e1106-e1115. PubMed ID: 35129464
[TBL] [Abstract][Full Text] [Related]
11. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
[TBL] [Abstract][Full Text] [Related]
12. Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era.
Mitra D; Ologun G; Keung EZ; Goepfert RP; Amaria RN; Ross MI; Gershenwald JE; Lucci A; Fisher SB; Davies MA; Lee JE; Bishop AJ; Farooqi AS; Wargo J; Guadagnolo BA
Ann Surg Oncol; 2021 Jul; 28(7):3480-3489. PubMed ID: 33856603
[TBL] [Abstract][Full Text] [Related]
13. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
14. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
Wong SL; Morton DL; Thompson JF; Gershenwald JE; Leong SP; Reintgen DS; Gutman H; Sabel MS; Carlson GW; McMasters KM; Tyler DS; Goydos JS; Eggermont AM; Nieweg OE; Cosimi AB; Riker AI; G Coit D
Ann Surg Oncol; 2006 Jun; 13(6):809-16. PubMed ID: 16604476
[TBL] [Abstract][Full Text] [Related]
15. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract][Full Text] [Related]
16. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
McMasters KM; Egger ME; Edwards MJ; Ross MI; Reintgen DS; Noyes RD; Martin RC; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; Davidson BS; Gershenwald JE; Hagendoorn LJ; Stromberg AJ; Scoggins CR
J Clin Oncol; 2016 Apr; 34(10):1079-86. PubMed ID: 26858331
[TBL] [Abstract][Full Text] [Related]
17. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.
Masoud SJ; Perone JA; Farrow NE; Mosca PJ; Tyler DS; Beasley GM
Curr Treat Options Oncol; 2018 Sep; 19(11):55. PubMed ID: 30232648
[TBL] [Abstract][Full Text] [Related]
18. The Role of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma.
Hieken TJ; Kane JM; Wong SL
Ann Surg Oncol; 2019 Apr; 26(4):1028-1034. PubMed ID: 30284132
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Outcomes Between Surveillance Ultrasound and Completion Lymph Node Dissection in Children and Adolescents With Sentinel Lymph Node-Positive Cutaneous Melanoma.
Scoville SD; Stanek JR; Rinehardt H; Sutthatarn P; Abdelhafeez AH; Talbot LJ; Malek M; Leraas HJ; Tracy ET; Chen SY; Kim ES; Lotakis DM; Ehrlich PF; Favela JG; Le HD; Davidson J; Wilson CA; Seemann NM; Osman Y; Piche N; Hoang V; Petroze RT; Polites SF; McKay KG; Correa H; Lovvorn HN; Lee YM; Balagani A; Dasgupta R; Aldrink JH
Ann Surg; 2024 Mar; 279(3):536-541. PubMed ID: 37487006
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.
Torphy RJ; Friedman C; Ho F; Leonard LD; Thieu D; Lewis KD; Medina TM; Robinson WA; Gonzalez RC; Stewart CL; Kounalakis N; McCarter MD; Gleisner A
Ann Surg Oncol; 2022 Feb; 29(2):806-815. PubMed ID: 34537899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
